MiAR Aortic Root Cannula with Flow-GuardRecalls & reported problems across all models
Medtronic, Inc. · 2 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
2 open recalls name at least one MiAR Aortic Root Cannula with Flow-Guard model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls
- 2
We found 2 models of MiAR Aortic Root Cannula with Flow-Guard by Medtronic, Inc. in the FDA's device registry (GUDID). Together they are named in 2 adverse event reports in the FDA's MAUDE database, received between Jan 25, 2024 and Oct 23, 2025 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Contamination” (1 report).
2 FDA recall records name at least one of these models by its device identifier, 2 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
MiAR Aortic Root Cannula with Flow-Guard recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Feb 5, 2025Open, Classified
Unexpected loose material in the male luer used in the aortic root cannula has been identified. Potential harms when identified prior to use - procedure delay. Potential harm if not identified and used - stroke (reversible and irreversible).
Z-1306-2025 · Root cause: Process control · names 2 of these models · Recall details · FDA record ↗
- Mar 19, 2024Open, Classified
Potential for unsealed sterile packing.
Z-1800-2024 · Root cause: Process control · Recall details · FDA record ↗
Most reported MiAR Aortic Root Cannula with Flow-Guard problems
Device problems
- Contamination1
- Manufacturing, Packaging or Shipping Problem1
- Misassembled During Installation1
- Packaging Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
MiAR Aortic Root Cannula with Flow-Guard models
2 models, most reported first. Each model has its own page with its reports, recalls and device details.
- MiAR™ Aortic Root Cannula with Flow-Guard™ 11014LCATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS2 recalls2 reports
- MiAR™ Aortic Root Cannula with Flow-Guard™ 11012LCATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS1 recall0 reports
Recent MiAR Aortic Root Cannula with Flow-Guard adverse event reports
The 2 most recent reports across all models, in the reporter's own words as published by the FDA.
MalfunctionOct 23, 2025Manufacturing, Packaging or Shipping Problem; Packaging Problem; Misassembled During Installation; Manufacturing, Packaging or Shipping Problem; Packaging Problem; Misassembled During Installation
MEDTRONIC RECEIVED INFORMATION THAT PRIOR TO USE OF A MIAR CANNULA, THE CUSTOMER REPORTED THAT THE PRODUCT WAS OUT OF THE PACKAGE. THERE WAS NO PATIENT INVOLVEMENT, SO NO ADVERSE EFFECT OCCURRED. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE DEVICE WAS NOT MISSING FROM THE PACKAGING. THE TIP SHEATH HAD COME OFF THE CANNULA, AND THE INTRODUCER NEEDLE WAS PROTRUDING THROUGH THE POUCH. THERE WAS DAMAGE TO THE PACKAGING, AND THE STERILE SEAL WAS NOT INTACT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23365748 ↗InjuryJan 25, 2024Contamination; Contamination
MEDTRONIC RECEIVED INFORMATION THAT DURING USE OF THIS MINIMALLY INVASIVE AORTIC ROOT (MIAR), IT WAS REPORTED THAT AFTER GOING TO CONNECT THE CARDIOPLEGIA LINE TO THE CANNULA, IT HAD A SMALL PIECE OF PLASTIC INSIDE OF NEEDLE. IT WAS REPORTED THAT THE PLASTIC FLOATED UPWARDS WITH THE BLOOD, WHERE IT WAS REMOVED AND THE NEEDLE WAS RINSED THOROUGHLY WITH THE PATIENT¿S OWN BLOOD. THE CUSTOMER USED THE CARDIOPLEGIA NEEDLE FOR PROCEDURE. THERE WAS NO ADVERSE PATIENT EFFECT REPORTED WITH THIS EVENT. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THE STERILE BARRIER WAS NOT STILL SEALED WHEN THE FOREIGN MATERIAL WAS IDENTIFIED. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT ACCORDING TO THE HEALTH CARE PROFESSIONAL THAT WAS INVOLVED IN INCIDENT, THE LOOSE FRAGMENT COULD HAVE EMBOLIZED INTO THE PATIENT'S ARTERIAL CIRCULATION AFTER THE HEART-LUNG MACHINE WAS STARTED AND CAUSED DAMAGE AND ISCHEMIA.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18578489 ↗
Other Medtronic, Inc. products
- CapSureFix Novus MRI SureScan29 models · 87,337 reports
- Medtronic Sprint Quattro Lead67 models · 45,880 reports · 1 recall
- Intellis AdaptiveStim3 models · 35,469 reports
- SYNCHROMED II11 models · 32,260 reports · 4 recalls
- CAPSUREFIX NOVUS17 models · 27,547 reports
- INTERSTIM30 models · 24,415 reports · 1 recall
- Sprint Quattro Secure S MRI SureScan7 models · 23,549 reports
- Medtronic LINQ Heart Monitor11 models · 19,366 reports · 3 recalls
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page